United Guardian Inc (NASDAQ:UG) Sentiment Worsened, Despite

November 21, 2017 - By Dolores Ford

 United Guardian Inc (NASDAQ:UG) Sentiment  Worsened,  Despite

Sentiment for United Guardian Inc (NASDAQ:UG)

United Guardian Inc (NASDAQ:UG) institutional sentiment decreased to 0.78 in Q2 2017. Its down -1.22, from 2 in 2017Q1. The ratio fall, as 7 institutional investors increased or opened new positions, while 9 sold and decreased positions in United Guardian Inc. The institutional investors in our partner’s database now have: 1.03 million shares, down from 1.04 million shares in 2017Q1. Also, the number of institutional investors holding United Guardian Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 9 Increased: 6 New Position: 1.

United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The company has market cap of $75.23 million. The Firm also conducts research and product development, primarily related to the development of cosmetic and personal care products. It has a 21.02 P/E ratio. The Company’s research and development department also modifies, refines, and expands the uses for existing products.

About 2,283 shares traded. United-Guardian, Inc. (NASDAQ:UG) has declined 10.72% since November 21, 2016 and is downtrending. It has underperformed by 27.42% the S&P500.

Parthenon Llc holds 0.41% of its portfolio in United-Guardian, Inc. for 111,547 shares. Northstar Group Inc. owns 32,538 shares or 0.31% of their US portfolio. Moreover, Teton Advisors Inc. has 0.12% invested in the company for 77,900 shares. The Connecticut-based Eagle Ridge Investment Management has invested 0.04% in the stock. Frontier Investment Mgmt Co, a Texas-based fund reported 11,000 shares.#img1#

More notable recent United-Guardian, Inc. (NASDAQ:UG) news were published by: Globenewswire.com which released: “United-Guardian Reports Strong Nine-Month Financial Results” on November 09, 2017, also Globenewswire.com with their article: “United-Guardian Receives FDA Approval to Market New Single-Dose Form of Renacidin®” published on January 04, 2016, Seekingalpha.com published: “United Guardian: Is The Current 5.4% Dividend Safe?” on April 22, 2016. More interesting news about United-Guardian, Inc. (NASDAQ:UG) were released by: Seekingalpha.com and their article: “United Guardian Offering A 5% Yield With A Shareholder-Friendly Board Of Directors” published on December 12, 2015 as well as Quotes.Wsj.com‘s news article titled: “United-Guardian Inc.” with publication date: February 11, 2011.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.